Quick Take
- GIMS Greater Noida held Uttar Pradeshβs first Startup Clinic on August 18, 2026, bringing together nearly 40 healthcare startups.
- Alkemi Growth Capital, which runs a Rs 1,000 crore healthcare fund and writes Rs 20 crore to Rs 25 crore cheques, ran an investment-readiness workshop.
- A CDSCO regulatory clinic followed, giving MedTech founders direct answers on medical device and IVD approvals.
The Government Institute of Medical Sciences in Greater Noida held Uttar Pradeshβs first Startup Clinic on August 18, 2026. The event brought together nearly 40 healthcare, MedTech and HealthTech startups from across the state.
The clinic was organised by the Centre for Medical Innovation, or CMI, at GIMS. It ran with Alkemi Growth Capital under StartInUP, the state governmentβs startup programme.
STPI, the MedTech Centre of Excellence in Lucknow, and the UP Promote Pharma Council also took part.
Who is Alkemi Growth Capital?
Alkemi Growth Capital anchored the day. It is a SEBI-registered Category II Alternative Investment Fund. It runs a Rs 1,000 crore healthcare-focused fund and typically writes cheques of Rs 20 crore to Rs 25 crore. That size marks it as a late-stage investor, not a seed backer.
Alka Goel, Founding Partner at Alkemi Funds, ran an Investment Readiness Workshop. She spent nearly two hours with founders. She explained how institutional investors judge healthcare companies before they write a cheque.
One number, two different funds. Uttar Pradeshβs own state startup fund, approved in the UP Startup Policy 2026, is also Rs 1,000 crore, routed through SIDBI. Alkemiβs Rs 1,000 crore is a private, separate pool. The two funds are not connected.
What did the Startup Clinic offer founders?
The clinic gave startups one platform for several needs. Founders got help on clinical validation, investment readiness, regulatory compliance, incubation, funding and business scale-up. Each is a step most MedTech founders face alone.
Alok Kumar, Principal Secretary for IT and Electronics in the state government, was the chief guest. He said Uttar Pradesh can become a national hub for medical device design and manufacturing. He pointed to the stateβs talent pool, industrial base and growing healthcare infrastructure.
Dr. Rahul Singh, CEO of the Centre for Medical Innovation, called the clinic a milestone for the stateβs healthcare startup ecosystem. He said the aim is not just to help startups raise money. It is to build companies worth investing in.
Dr. (Brig.) Rakesh Gupta, Director of GIMS, described CMI as more than an incubation centre. He said it is a platform where doctors, engineers and management professionals work together. Doctors spot the clinical need, engineers build the fix, and managers turn it into a business.
What happened at the CDSCO regulatory clinic?
The second half of the day featured the CDSCO-GIMS Regulatory Clinic. It ran from 3:00 PM to 4:30 PM. It focused on medical devices and in-vitro diagnostics, a category known as IVD.
Experts from the Central Drugs Standard Control Organisation answered founder questions on approvals, testing and market entry. Dr. Vandana Srivastava, Director of STPI-Noida and CEO of the MedTech Centre of Excellence, spoke on technology entrepreneurship. Dr. Sandeep Sharma of the UP Promote Pharma Council also addressed institutional support for health ventures.
Why does the hospital-based model matter?
The hospital-based model drew the most interest. Startups toured the incubation facilities inside GIMS. A government hospital gives founders direct access to clinicians, patients and real clinical problems. That access is hard to buy anywhere else.
GIMS is not new to this work. CMI is the first government hospital-based medical incubator in Uttar Pradesh. It runs as a State Government Section 8 company under the Department of Medical Education.
The model has already produced a result. In November 2025, a CMI-incubated startup, Sophrosyne Technologies, raised about Rs 16.6 crore in seed funding.
Alkemi has backed one Noida healthcare venture this year too. In May 2026, robotics firm Alphadroid raised Rs 36 crore in a pre-Series A round led by Alkemi Growth Capital. The fund knows the stateβs healthcare hardware scene.
What this means for you: If you run a MedTech or HealthTech startup in Uttar Pradesh, CMI at GIMS is now a direct line to a Rs 1,000 crore healthcare investor and to CDSCO regulators in one place. Get your clinical validation and compliance file ready before the next clinic.
StartupFeed Insight
The signal here is not the workshop. It is who showed up to run it. Alkemi writes Rs 20 crore to Rs 25 crore cheques, and it already led Alphadroidβs Rs 36 crore round in Noida in May 2026. A late-stage healthcare fund does not spend a day at a government hospital unless it expects real deal flow from that pipeline. GIMS has the ingredients few incubators own: live patients, clinicians and a Section 8 structure. Watch for at least one Alkemi term sheet to a CMI-linked startup by June 2027. The hospital-based model is quietly becoming UPβs strongest MedTech funnel.
β Avinash Mishra, Business Correspondent
Frequently Asked Questions
Have a tip? Write to us at editorial@startupfeed.in.



